Det kan anbefales at levodopadosis reduceres både under dosisstigning og vedligeholdelsesbehandling med Oprymea, afhængigt af den enkelte patients reaktioner.
It is recommended that the dosage of levodopa is reduced during both the dose escalation and the maintenance treatment with Oprymea, depending on reactions in individual patients.